TotalMarketCap

Akari Therapeutics

AKTXNasdaq United KingdomHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$17.504 M

$7.66 -12.96%

Close of 6 Nov 2026

As of 6 Nov 2026, Akari Therapeutics (AKTX) has a market capitalization of $17.5M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$17.3M

Loss-making

Shares outstanding

91,567,009,533

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #388Actuate TherapeuticsACTU$18.4M
  2. #389Quantum BiopharmaQNTM$17.8M
  3. #390Akari TherapeuticsAKTX$17.5M
  4. #391Context TherapeuticsCNTX$17.2M
  5. #392Pasithea TherapeuticsKTTA$16.8M

What if Akari Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$12,356,602

Per share 1,613,133× higher

Bitcoin $1.53T

$668,594.20

Per share 87,284× higher

Apple $5.02T

$2,194,932

Per share 286,545× higher

Or at a round number

$50.0M$100.0M$200.0M$500.0M

Where these numbers come from

Share counts and financials for Akari Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.